Effect of emerging antiobesity and antidiabetic drugs on atherosclerosis

Intern Emerg Med. 2026 Jun 18. doi: 10.1007/s11739-026-04438-3. Online ahead of print.ABSTRACTType 2 diabetes mellitus and obesity constitute major global public health concerns, with their incidence continuing to rise worldwide. These metabolic conditions are closely interrelated and commonly coexi

G Giuseppe Armentaro

Von Hippel-Lindau disease: pathophysiological and clinical advances

Fam Cancer. 2026 Jun 18;25(3):65. doi: 10.1007/s10689-026-00579-8.ABSTRACTVon Hippel-Lindau (VHL) disease is a hereditary tumor predisposition syndrome caused by pathogenic germline variants in the VHL gene. Patients with VHL disease have an increased risk of developing characteristic VHL disease-as

S S J van Alfen

Endothelial Cell Phenotypic Plasticity in Atherosclerosis

Handb Exp Pharmacol. 2026 Jun 19. doi: 10.1007/164_2026_814. Online ahead of print.ABSTRACTAtherosclerosis, the leading cause of cardiovascular death worldwide, is initiated by endothelial cells (ECs) dysfunction and sustained by maladaptive vascular remodeling. Far from being a uniform barrier, the

L Laura Alonso-Herranz

Awareness and early implementation of the European AIDS Clinical Society Guidance on statin use in HIV for the primary prevention of cardiovascular disease: A cross-sectional survey of HIV clinicians in Europe

HIV Med. 2026 Jun 18. doi: 10.1111/hiv.70271. Online ahead of print.ABSTRACTOBJECTIVES: Cardiovascular disease (CVD) is a major comorbidity and leading cause of morbidity and mortality in people with HIV (PWH). The REPRIEVE trial demonstrated that statin therapy significantly reduces cardiovascular

J Jasmini Alagaratnam

Swiss obesity clinical practice guidance

Swiss Med Wkly. 2026 May 19;156:5415. doi: 10.57187/5415.ABSTRACTObesity is a chronic, relapsing, and multifactorial disease that poses a significant public health challenge in Switzerland, where approximately 43% of adults are overweight or obese. This new clinical practice guidance establishes a s

P Philipp A Gerber

A Machine Learning Driven Approach to Quantifying Coronary Artery Tortuosity

JACC Adv. 2026 Jun;5(6 Pt 2):102829. doi: 10.1016/j.jacadv.2026.102829.ABSTRACTBACKGROUND: The associations between coronary artery tortuosity and age, sex, and cardiovascular risk factors are not fully established. Prior studies enrolled fewer than 1,000 subjects and relied on heuristic metrics.OBJ

J Jose Roberto Tello Ayala